A substantial proportion of patients fail to achieve sustained remission. Treatment resistance remains common, and relapse frequently follows initial response. These patterns suggest a structural limitation: incremental adjustments to synaptic signaling are no longer sufficient to meaningfully shift long-term outcomes at scale.